In AD, laminin expression is altered, with reductions observed in the brain microvasculature of transgenic models and BBB dysfunction linked to impaired capillary density (Anwar et al. 2022; Ma et al. 2020). The gene discussed is LAMB2; the disease is Alzheimer disease.